Literature DB >> 6156044

Antigens of the human liver.

I G McFarlane, B M Wojcicka, R Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156044      PMCID: PMC1536951     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  45 in total

1.  THE LOSS OF PROTEIN IN HUMAN AND CANINE HEPATIC BILE.

Authors:  J HARDWICKE; J G RANKIN; K J BAKER; R PREISIG
Journal:  Clin Sci       Date:  1964-06       Impact factor: 6.124

Review 2.  Clinical relevance of the liver-specific lipoprotein (lsp).

Authors:  T H Hütteroth; K H Meyer zum Büschenfelde
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1978-06

3.  A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5.

Authors:  M T Labro; M C Andrieu; M Weber; J C Homberg
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

4.  Immunohistologic demonstration of hepatitis B viral antigens in liver with reference to its significance in liver injury.

Authors:  S N Huang; A R Neurath
Journal:  Lab Invest       Date:  1979-01       Impact factor: 5.662

5.  Liver-specific and shared cell membrane antigens. Studies by light- and electron microscopy.

Authors:  U J Behrens; F Paronetto
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

6.  Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.

Authors:  S Kakumu; Y Arakawa; H Goji; T Kashio; K Yata
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

7.  LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?

Authors:  K H Meyer zum Büschenfelde; M Manns; T H Hütteroth; U Hopf; W Arnold
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

9.  Immunofluorescence studies on the occurrence and localization of the CEA-related biliary glycoprotein I (BGP I) in normal human gastrointestinal tissues.

Authors:  T Svenberg; S Hammarström; J Zeromski
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

10.  Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; B C Portmann; A L Eddleston; R Williams
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

View more
  13 in total

1.  The relationship between liver-specific lipoprotein and the hepatocyte plasma membrane.

Authors:  W N Bartholomaeus; N R Swanson; W D Reed; H L O'Donoghue; D Foti; J M Papadimitriou
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

2.  Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.

Authors:  A Lobo-Yeo; G Mieli-Vergani; G Kenna; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M McFarlane; G N Major; P Tolley; R Williams
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

4.  Characterization and demonstration of human liver-specific protein (LSP) and apo-LSP.

Authors:  N Lebwohl; M A Gerber
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

5.  [Detection of liver cell membrane antibodies in patients with viral hepatitis].

Authors:  L J Hao; S X Shi; F G Li; Y K Wang
Journal:  Acta Acad Med Wuhan       Date:  1982

Review 6.  Genetic determinants of autoimmune chronic active hepatitis.

Authors:  I R Mackay; S Whittingham; J D Mathews; B D Tait
Journal:  Springer Semin Immunopathol       Date:  1980-12

7.  Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease.

Authors:  A Perperas; D Tsantoulas; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

8.  Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis.

Authors:  J Neuberger; G Mieli-Vergani; J M Tredger; M Davis; R Williams
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

9.  Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class.

Authors:  A D Burt; R S Anthony; W S Hislop; I A Bouchier; R N MacSween
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

10.  Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.

Authors:  I H Frazer; I R Mackay
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.